TY - JOUR T1 - SARS-CoV-2 vaccines in patients with SLE JF - Lupus Science & Medicine JO - Lupus Sci Med DO - 10.1136/lupus-2021-000479 VL - 8 IS - 1 SP - e000479 AU - Wei Tang AU - Anca D Askanase AU - Leila Khalili AU - Joan T Merrill Y1 - 2021/03/01 UR - http://lupus.bmj.com/content/8/1/e000479.abstract N2 - As the Moderna (mRNA-1273) and Pfizer/BioNTech (BNT162b2) vaccines become available to patients with autoimmune diseases and SLE, practitioners will have to inform them about the safety and efficacy of these vaccines. Here we discuss the challenges of applying vaccine data to patients with autoimmune diseases and the evidence available in the literature that may help in the decision process. ER -